Anavex/Biogen collaboration MIGHT be Classic WIN/WIN.
Imagine a hypothetical deal involving ten million preferred shares.
(I am just posing numbers for example)
10 Mil Preferred Shares(20% equity stake) for say $20 a share. Anavex gets $200 Mil. to develop the pipeline for which BIIB will own 20% and have exclusive licencing rights to MS indications, BIIB will of course take over those MS trials.
I very good deal for BIIB in MHO.
Also solves all Anavex financing for years possibility never having to raise capital before approvals. And keeping 80% of the pipeline for AVXL stockholders.
Now imagine what will be the Market Cap valuation of AVXL rise to within months after this deal is announced especially with commencement of the clinical trials in Rett's, Parkinson's and ALZ? If only rises to be equal to that of Axovant approx $1.5 Bil. ( AXON A company with an inferior pipeline but with 100s of millions in cash) Then that will be a six bagger from here or approx $36 a share.
BIIB got a great licensing deal on the cheap, AND almost doubled it's investment in short order.
Avavex got one of the Primary things it needs to develop AVXL pipeline, CASH.
EVERYBODY WINS! Anavex, Biogen,both AVXL and BIIB shareholders and most importantly millions of suffering human beings
Go Anavex/Biogen!
News 
Market Data 
Discover 
